Biocon Limited

Biocon Limited

Share · INE376G01013 (XBOM)
Overview
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of Biocon Limited
No Price
Closing Price XBOM 29.04.2026: 365,90 INR
29.04.2026 05:36
Current Prices from Biocon Limited
ExchangeTickerCurrencyLast TradePriceDaily Change
XNSE: NSE
NSE
BIOCON.NS
INR
29.04.2026 05:36
366,25 INR
3,45 INR
+0,95 %
XBOM: MSE
MSE
BIOCON.BO
INR
29.04.2026 05:21
365,90 INR
3,10 INR
+0,85 %
Share Float & Liquidity
Free Float 45,94 %
Shares Float 583,07 M
Shares Outstanding 1,27 B
Invested Funds

The following funds have invested in Biocon Limited:

Fund
iShares MSCI India UCITS ETF USD (Acc)
Vol. in million
2.478,35
Percentage (%)
0,21 %
Fund
iShares MSCI EM Islamic UCITS ETF USD (Dist)
Vol. in million
103,20
Percentage (%)
0,10 %
Fund
iShares MSCI EM ex-China UCITS ETF USD (Acc)
Vol. in million
6,81
Percentage (%)
0,04 %
Fund
iShares MSCI EM IMI ESG Screened UCITS ETF USD (Dist)
Vol. in million
86,16
Percentage (%)
0,03 %
Fund
iShares MSCI EM IMI ESG Screened UCITS ETF USD (Acc)
Vol. in million
436,15
Percentage (%)
0,03 %
Company Profile for Biocon Limited Share
Biocon Limited, a biopharmaceutical company, manufactures pharmaceuticals, and medicinal chemical and botanical products. The company operates through Generics, Novel Biologics, Biosimilars, and Research Services segments. It focuses in the areas of diabetes, oncology, immunology, ophthalmology, and bone health diseases. In addition, It is involved in the integrated discovery, development, and manufacturing services for small and large molecules. The company serves customers in approximately 120 countries. Biocon Limited was founded in 1978 and is headquartered in Bengaluru, India.

Company Data

Name Biocon Limited
Company Biocon Limited
Website https://www.biocon.com
Primary Exchange XBOM MSE
ISIN INE376G01013
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Siddharth Mittal BCom, CA, CPA
Market Capitalization 460 Mrd.
Country India
Currency INR
Employees 16,3 T
Address 20th KM, Hosur Road, 560100 Bengaluru
IPO Date 2004-04-07
Dividends from 'Biocon Limited'
Ex-Date Dividend per Share
04.07.2025 0,50 INR
05.07.2024 0,50 INR
07.07.2023 1,50 INR
30.06.2022 0,50 INR
18.07.2019 0,50 INR
19.07.2018 1,00 INR
20.07.2017 1,00 INR
17.03.2016 5,00 INR
17.03.2016 15,00 INR
09.04.2015 5,00 INR

Stock Splits

Date Split
12.06.2019 2:1
15.06.2017 3:1
11.09.2008 1:3

Ticker Symbols

Name Symbol
MSE BIOCON.BO
NSE BIOCON.NS
More Shares
Investors who hold Biocon Limited also have the following shares in their portfolio:
EUR/DOP DOMINIKANISCHER PESO
EUR/DOP DOMINIKANISCHER PESO Currency
Mineralys Therapeutics, Inc. - Common Stock
Mineralys Therapeutics, Inc. - Common Stock Share